THAAPP Research

The evaluation of the effects of Alaska Pollack protein for locomotion after Total Hip Arthroplasty (THAAPP Research) - THAAPP Research

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs061230002

Enrollment

150

Registered

2023-04-11

Start date

2023-06-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of hip joint, Osteonecrosis of the femoral head, Acetabula

Interventions

reated with 4.5 g/day of protein derived from whey or APP.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients treated with Total Hip Arthroplasty

Exclusion criteria

Exclusion criteria: Palsy of lower extremities, Renal dysfunction, Hepatic dysfunction, Allergic to pollock or whey-derived protein, milk, wheat, or soy.

Design outcomes

Primary

Measure	Time frame
Difference of muscular function of lower extremities	—

Secondary

Measure	Time frame
Difference of locomotive syndrome score, Physical activity, muscle volume evaluated by a CT scan	—

Contacts

Public ContactTomofumi Kinoshita

Ehime University Graduate School of Medicine

kinoshita.tomofumi.ca@ehime-u.ac.jp+81-89-960-5925

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026